Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/2007
01/11/2007DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing
01/11/2007CA2642008A1 Methods and compositions for improving pregnancy outcome
01/11/2007CA2614315A1 Activator of peroxisome proliferator activated receptor d
01/11/2007CA2614210A1 Methods and compositions for improving pregnancy outcome
01/10/2007EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
01/10/2007EP1741703A1 Pyridone derivative
01/10/2007EP1741433A1 Pharmaceutical composition comprising an androgen
01/10/2007EP1740181A1 New pharmaceutical compositions for the treatment of sexual disorders ii
01/10/2007EP1740180A1 Use of flibanserin in the treatment of premenstrual and other female sexual disorders
01/10/2007EP1740163A2 Multi-phase contraceptive preparation based on a natural estrogen
01/10/2007EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells
01/10/2007EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
01/10/2007EP1313491B1 Bioactive fraction of eurycoma longifolia
01/10/2007EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
01/10/2007EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence
01/10/2007CN1894245A Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors
01/10/2007CN1894244A Aryl ether substituted imidazoquinolines
01/10/2007CN1894195A Ether compounds and compositions for cholesterol management and related uses
01/10/2007CN1893969A Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility
01/10/2007CN1893968A Regulation of sperm function
01/10/2007CN1893963A Production of hop extracts having oestrogenic and antiproliferative bioactivity
01/10/2007CN1891288A Chinese medicine composition, and its preparing method and quality control method
01/10/2007CN1891285A Chinese medicine composition, and its preparing method and quality control method
01/10/2007CN1891272A Chinese medicine health care panties special for women
01/10/2007CN1891262A Chinese medicine compound preparation for treating gynaecologic inflammation and its preparing method
01/10/2007CN1891227A 偏诺皂苷类化合物注射制剂 Partial promise saponin compound injectable formulations
01/10/2007CN1891226A 偏诺皂苷类化合物注射制剂 Partial promise saponin compound injectable formulations
01/10/2007CN1891224A Progestational hormone composition, and its slow-release suppository device and preparation of said device
01/10/2007CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
01/10/2007CN1294143C Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
01/10/2007CN1294131C Pyrimidine compound
01/10/2007CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/10/2007CN1293893C Gel of Chinese traditional medicine for treating cervicitis, cervical erosion and colpitis and preparation method thereof
01/10/2007CN1293890C Ointment of Chinese traditional medicine for treating hyperplasia of mammary glands, and preparation method
01/09/2007US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
01/09/2007US7160889 Quinazoline compounds
01/09/2007US7160886 For therapy and prophylaxis of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
01/09/2007US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
01/09/2007CA2286190C Gnrh antagonists being modified in positions 5 and 6
01/09/2007CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia
01/04/2007WO2007002910A1 Quadraphasic continuous graduated estrogen contraceptive
01/04/2007WO2007002862A2 Compositions and methods for treatment of cycle-related symptoms
01/04/2007WO2007002174A2 A method of treatment of hormone depletion induced vasomotor symptoms
01/04/2007WO2007001841A1 Treatment of sexual dysfunction
01/04/2007WO2007000764A2 Compositions and methods for enhancement of sexual function
01/04/2007WO2007000056A1 Aromatase inhibitors for emergency contraception
01/04/2007US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases
01/04/2007US20070004718 Ion channel modulating compounds and uses thereof
01/04/2007US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis
01/04/2007US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin
01/04/2007US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus
01/04/2007US20070004619 Relaxin superfamily peptide analogues
01/04/2007US20070003642 Composition containing high concentration of isoflavone and having high solubility and process for producing the same
01/04/2007US20070003556 Modified antibodies against cd22 and utilization thereof
01/04/2007CA2619503A1 Aromatase inhibitors for emergency contraception
01/04/2007CA2613617A1 Compositions and methods for enhancement of sexual function
01/04/2007CA2612885A1 Compositions and methods for treatment of cycle-related symptoms
01/04/2007CA2612672A1 Treatment for sexual dysfunction
01/04/2007CA2609336A1 Quadraphasic continuous graduated estrogen contraceptive
01/03/2007EP1738754A1 Solid pharmaceutical preparation
01/03/2007EP1737429A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
01/03/2007EP1429753B1 Pharmaceutical composition comprising gamma-butyrobetaine
01/03/2007EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
01/03/2007EP1267826B1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion
01/03/2007EP1221439B1 Tetrahydroquinoline derivatives
01/03/2007EP0929315B1 Cross-protective equine herpesvirus preparations and method of making and using the same
01/03/2007CN1888051A Plant lactobacillus strain and its application
01/03/2007CN1887342A Medicine prepn for treating cow's mammitis and its prepn and use
01/03/2007CN1887323A Chinese medicine composition and its prepn process and quality control method
01/03/2007CN1887313A Chinese medicine composition for treating male's sterility and its prepn
01/03/2007CN1887287A New use of mifepristone
01/03/2007CN1887253A Intelligent' gel and its application in contraception
01/03/2007CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens
01/03/2007CN1293074C Arylindenopyridines with PDE inhibiting activity
01/03/2007CN1293061C Novel branched substituted amino derivatives of 3-amino-1-phemyl-1H-[1,2,4]triazo, methods for producing them and pharmaceutica compositions containing them
01/03/2007CN1293059C New Carboxglic acid derivative, its preparation and application
01/03/2007CN1292796C Controlled release composition and method of producing the same
01/03/2007CN1292791C Medicine composition for treating amenorrhea and preparation thereof
01/03/2007CN1292788C Chinese medicine composition for treating infertility of male and female
01/03/2007CN1292764C Chinese medicinal pill for treating postpartum disease and gynecopathy
01/03/2007CN1292758C Paste for treating premature ejaculation
01/02/2007US7157604 Selective estrogen receptor modulators
01/02/2007US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
01/02/2007US7157552 Mutant trichosanthin
01/02/2007US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists
01/02/2007US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor
01/02/2007CA2436275C Polymeric delivery formulations of leuprolide with improved efficacy
01/02/2007CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors
01/02/2007CA2174517C Receptor specific atrial natriuretic peptides
12/2006
12/28/2006WO2006138038A1 Intralesional treatment of psoriasis
12/28/2006WO2006137469A1 Metabotropic glutamate receptor activator
12/28/2006WO2006136462A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
12/28/2006WO2005097193A3 Sequential sprm/progestin treatment
12/28/2006US20060293347 Pharmaceutically active compounds
12/28/2006US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006US20060292131 Chondrocyte Therapeutic Delivery System
12/28/2006CA2633030A1 Intralesional treatment of psoriasis
12/28/2006CA2612387A1 Modulators of sperm hypermotility and uses thereof
12/28/2006CA2611900A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators